Johnson & Johnson (UKEX:JNJ)
â‚´ 5947 0 (0%) Market Cap: 14.82 Til Enterprise Value: 15.47 Til PE Ratio: 24.01 PB Ratio: 4.98 GF Score: 84/100

Q3 2021 Johnson & Johnson Earnings Call Transcript

Oct 19, 2021 / 12:30PM GMT
Operator

Good morning, and welcome to Johnson & Johnson's Third Quarter 2021 Earnings Conference Call. (Operator Instructions) This call is being recorded. If you have any objections, you may disconnect at this time. (Operator Instructions)

I would now like to turn the call over to Johnson & Johnson. You may now begin.

Sarah Wood
Johnson & Johnson - Senior Director Investor Relations

Good morning. This is Sarah Wood, Senior Director, Investor Relations for Johnson & Johnson. Welcome to our company's review of business results for the third quarter and our updated financial outlook for 2021.

On today's call is Joe Wolk, Executive Vice President, Chief Financial Officer. And during the Q&A portion of the call, Joe will be joined by Ashley McEvoy, Executive Vice President and Worldwide Chair, Medical Devices; Thibaut Mongon, Executive Vice President and Worldwide Chair, Consumer Health; and Jennifer Taubert, Executive Vice President and Worldwide Chair, Pharmaceuticals.

A few logistics before we get into the details. This

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot